Athersys logo

Athersys

Committed to developing therapies to extend and enhance the quality of life.

37 employees · est. 1995 · Cleveland, United States

VS
InMed Pharmaceuticals logo

InMed Pharmaceuticals

Global leader in the manufacturing and development of rare cannabinoids. Our subsidiary is Baymedica. Nasdaq: $INM

18 employees · est. 1981 · Canada

InMed Pharmaceuticals is the older company (1995 vs 1981).

Side-by-Side Comparison

Athersys InMed Pharmaceuticals
Founded
1995 1981 older
Headquarters
Cleveland, United States Canada
Employees
37 18
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Post Ipo Equity Post Ipo Equity
Total Funding
$208.90M Not tracked yet
Funding Rounds
9 13
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, Therapeutics, Clinical Stage, Drug Development, Regenerative Medicine, Stem Cell Therapy, Pharmaceuticals, Innovation, Disease Indications, Clinical Trials, Proprietary Technologies, Life-threatening Diseases, Quality Of Life, Multi-disease Indications Pharmaceuticals, Drug Development, Cannabinoids, Rare Cannabinoids, Therapeutic Medications, Alzheimer's Treatment, Ocular Indications, Dermatological Indications, Small Molecule Drugs, Clinical-stage Pharmaceuticals, CB1/CB2 Receptors, Medical Research
Website
athersys.com inmedpharma.com
Athersys logo

About Athersys

Athersys is a biopharmaceutical company committed to developing therapies to extend and enhance the quality of life. Established in 1995 and headquartered in the United States, Athersys focuses on the discovery and development of innovative medicines to treat significant and life-threatening disease...

InMed Pharmaceuticals logo

About InMed Pharmaceuticals

InMed Pharmaceuticals, founded in 1981, is a biotechnology company headquartered in Canada. The company is recognized as a global leader in the manufacturing and development of rare cannabinoids, strategically aligning with its subsidiary, BayMedica. With a focus on developing proprietary small mol...

We will tell you when either one moves

BounceWatch watches Athersys and InMed Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Athersys and InMed Pharmaceuticals — by email.

Frequently Asked Questions

Athersys — Committed to developing therapies to extend and enhance the quality of life.. InMed Pharmaceuticals — Global leader in the manufacturing and development of rare cannabinoids. Our subsidiary is Baymedica. Nasdaq: $INM. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Athersys has raised $208.90M while InMed Pharmaceuticals has raised undisclosed funding.
Athersys and InMed Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Athersys with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Athersys on 12 Sep 2024, and InMed Pharmaceuticals on 15 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy